These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 14709855

  • 21. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O.
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [Abstract] [Full Text] [Related]

  • 22. Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families.
    Sahakitrungruang T, Tee MK, Rattanachartnarong N, Shotelersuk V, Suphapeetiporn K, Miller WL.
    Horm Res Paediatr; 2010 Apr; 73(5):349-54. PubMed ID: 20389105
    [Abstract] [Full Text] [Related]

  • 23. Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus.
    Rocha JL, Friedman E, Boson W, Moreira A, Figueiredo B, Liberman B, de Lacerda L, Sandrini R, Graf H, Martins S, Puñales MK, De Marco L.
    Hum Mutat; 1999 Apr; 14(3):233-9. PubMed ID: 10477431
    [Abstract] [Full Text] [Related]

  • 24. Nephrogenic diabetes insipidus.
    Bichet DG.
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [Abstract] [Full Text] [Related]

  • 25. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.
    Pasel K, Schulz A, Timmermann K, Linnemann K, Hoeltzenbein M, Jääskeläinen J, Grüters A, Filler G, Schöneberg T.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1703-10. PubMed ID: 10770218
    [Abstract] [Full Text] [Related]

  • 26. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
    Faerch M, Christensen JH, Corydon TJ, Kamperis K, de Zegher F, Gregersen N, Robertson GL, Rittig S.
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):395-403. PubMed ID: 17941907
    [Abstract] [Full Text] [Related]

  • 27. Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus.
    Deen PM, Knoers NV.
    Am J Med Sci; 1998 Nov; 316(5):300-9. PubMed ID: 9822112
    [Abstract] [Full Text] [Related]

  • 28. A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus.
    Yokoyama K, Yamauchi A, Izumi M, Itoh T, Ando A, Imai E, Kamada T, Ueda N.
    J Am Soc Nephrol; 1996 Mar; 7(3):410-4. PubMed ID: 8704106
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Integrin-linked kinase regulates tubular aquaporin-2 content and intracellular location: a link between the extracellular matrix and water reabsorption.
    Cano-Peñalver JL, Griera M, Serrano I, Rodríguez-Puyol D, Dedhar S, de Frutos S, Rodríguez-Puyol M.
    FASEB J; 2014 Aug; 28(8):3645-59. PubMed ID: 24784577
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.
    Rochdi MD, Vargas GA, Carpentier E, Oligny-Longpré G, Chen S, Kovoor A, Gitelman SE, Rosenthal SM, von Zastrow M, Bouvier M.
    Mol Pharmacol; 2010 May; 77(5):836-45. PubMed ID: 20159941
    [Abstract] [Full Text] [Related]

  • 34. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
    Bichet DG, Turner M, Morin D.
    Proc Assoc Am Physicians; 1998 May; 110(5):387-94. PubMed ID: 9756088
    [Abstract] [Full Text] [Related]

  • 35. AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus.
    Ando F, Mori S, Yui N, Morimoto T, Nomura N, Sohara E, Rai T, Sasaki S, Kondo Y, Kagechika H, Uchida S.
    Nat Commun; 2018 Apr 12; 9(1):1411. PubMed ID: 29650969
    [Abstract] [Full Text] [Related]

  • 36. Genetic basis of nephrogenic diabetes insipidus.
    Hureaux M, Vargas-Poussou R.
    Mol Cell Endocrinol; 2023 Jan 15; 560():111825. PubMed ID: 36460218
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation.
    Zang L, Gong Y, Li Y, Dou J, Lyu Z, Su X, Zhang Y, Mu Y.
    Biomed Res Int; 2022 Jan 15; 2022():7073158. PubMed ID: 35865667
    [Abstract] [Full Text] [Related]

  • 39. Heteroligomerization of an Aquaporin-2 mutant with wild-type Aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus.
    Marr N, Bichet DG, Lonergan M, Arthus MF, Jeck N, Seyberth HW, Rosenthal W, van Os CH, Oksche A, Deen PM.
    Hum Mol Genet; 2002 Apr 01; 11(7):779-89. PubMed ID: 11929850
    [Abstract] [Full Text] [Related]

  • 40. A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.
    Schernthaner-Reiter MH, Adams D, Trivellin G, Ramnitz MS, Raygada M, Golas G, Faucz FR, Nilsson O, Nella AA, Dileepan K, Lodish M, Lee P, Tifft C, Markello T, Gahl W, Stratakis CA.
    Eur J Pediatr; 2016 May 01; 175(5):727-33. PubMed ID: 26795631
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.